Wednesday, February 24, 2016

Choice of Analgesia in SJS/TEN

NSAIDS
  • In most instances, Stevens-Johnson syndrome as a result of a nonsteroidal anti-inflammatory drug is drug-specific and therefore it is not universal that a patient will react to an alternative nonsteroidal
  • NSAIDs are not automatically discontinued in cases of Stevens-Johnson syndrome unless one of them is suspected to be the cause
  • no particular choice in this regard since although we do know that NSAIDS can cause Stevens-Johnson syndrome, we do not have enough data to distinguish those that might be "safer than others".
  • During SJS or TEN management, NSAIDS should not be used unless other medicines, such as opioids or paracetamol, do not work
Opiods
  • Pain control is an integral part of the management of SJS/TEN but there is not much literature available to guide one except for burn pain management.
  • SJS/TEN patients experience background pain which is present at rest and is of low intensity.
  • During procedures the pain is more intense and short-lived and the latter is referred to as procedural pain.
  • Pain management has to be individualised, taking into consideration the clinical needs of the patient, viable route of administration, risk of respiratory suppression and monitoring facilities.
  • In a non-ICU setting full consciousness is preferable as is oral therapy for reasons already mentioned.
  • Oral transmucosal, short-acting, medium-potency opioids are best for procedural pain.
  • Anxiolytics such as low-dose benzodiazepines can be added and these are more effective for patients with high pre-procedure anxiety and high baseline pain
  • Longer-acting, mild- to moderate-potency opioids together with paracetamol should be given for background pain
Dosing Recomendations
Paracetamol
  • children: 10-15 mg/kg orally every 4-6 hours when required, maximum 90 mg/kg/day
  • adults: 500-1000 mg orally every 4-6 hours when required, maximum 4000 mg/day
Morphine Sulphate
  • children: 0.05 to 0.2 mg/kg orally/intravenously every 2-4 hours when required, maximum 15 mg/kg; 
  • adults: 7.5-10 mg orally/intravenously every 4 hours when required

Reference:
  1. MANAGEMENT OF STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS. Current Allergy & Clinical Immunology, August 2007 Vol 20, No. 3
  2. http://www.aaaai.org/ask-the-expert/stevens-johnson-syndrome.aspx
  3. http://bestpractice.bmj.com.ezp.imu.edu.my/best-practice/monograph/237/treatment.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.